Application of "B+1" heterologous boosting strategy for preventing infection of SARS-CoV-2 variants with resistance to broad-spectrum coronavirus vaccines.
Emerg Microbes Infect
; 12(1): 2192817, 2023 Dec.
Article
in English
| MEDLINE | ID: covidwho-2269460
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
SARS-CoV-2
/
COVID-19
Topics:
Vaccines
/
Variants
Limits:
Humans
Language:
English
Journal:
Emerg Microbes Infect
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS